ArticleChest2025
CT Emphysema Subtypes and Cardiac Hemodynamics Estimated on MRI: The Multi-Ethnic Study of Atherosclerosis COPD Study.
Article in Chest, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The clinical relevance of chest computed tomography imaging in pulmonary hypertension associated with lung diseases.Current opinion in pulmonary medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
backgroundCOPD is traditionally associated with pulmonary hypertension, but treatments targeting elevated pulmonary artery pressure in COPD have largely failed, possibly due to an incomplete understanding of subphenotypes of the disease. RESEARCH QUESTION: Are novel machine-learned CT emphysema subtypes associated with specific cardiac hemodynamic profiles? STUDY DESIGN AND
methodsThe Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study recruited participants with and without COPD aged 50 to 79 years with ≥ 10 pack-years of smoking and without clinical cardiovascular disease, predominantly from MESA and a lung cancer screening cohort. COPD and COPD severity were defined by standard spirometric criteria. CT emphysema subtypes were defined by unsupervised machine learning in an independent study and labeled on chest CT scans. Hemodynamics were estimated on cardiac MRI using validated equations. Linear regression models were weighted by the inverse probability of sampling and adjusted for potential confounders.
resultsThe mean age of the 300 participants was 68 ± 7 years, 60% were male, 28% currently smoked, and 47% had COPD (45% of mild and 41% of moderate severity). More severe COPD was associated with lower estimated pulmonary arterial wedge pressure (ePAWP; P trend = .02) and greater estimated pulmonary vascular resistance (ePVR; P trend = .03) but not estimated pulmonary artery pressure (ePAP; P trend = 0.83). Only the combined bronchitic-apical emphysema subtype was associated with greater ePAP (1.08 mm Hg/10%; 95% CI, 0.40-1.75). The diffuse emphysema subtype was associated with lower ePAWP (-0.49 mm Hg/10%; 95% CI, -0.75 to -0.24) and greater ePVR (0.36 Wood units/10%; 95% CI, 0.10-0.61).
interpretationIn this case-control study of predominantly mild-moderate COPD, greater ePAP was specific to the combined bronchitic-apical emphysema subtype whereas the diffuse emphysema subtype and COPD severity were associated with lower ePAWP and greater ePVR. The CT emphysema subtype findings suggest more precise avenues to therapeutic interventions in cardiopulmonary dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.